Effect of the administration of Lactobacillus paracasei subsp. paracasei NTU 101 on Peyer's patch-mediated mucosal immunity
The role of lactic acid bacteria in gut mucosal immunity was investigated by comparing the enhanced effects in the Peyer's patches and spleen of BALB/c mice fed daily with Lactobacillus paracasei subsp. paracasei NTU 101 for 3 to 9 weeks. After feeding with Lactobacillus, the percentage of CD4...
Saved in:
Published in | International immunopharmacology Vol. 10; no. 7; pp. 791 - 798 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Kidlington
Elsevier B.V
01.07.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The role of lactic acid bacteria in gut mucosal immunity was investigated by comparing the enhanced effects in the Peyer's patches and spleen of BALB/c mice fed daily with
Lactobacillus paracasei subsp.
paracasei NTU 101 for 3 to 9
weeks. After feeding with
Lactobacillus, the percentage of CD4
+ T cells in both Peyer's patches and the spleen was significantly increased; however, expression of CD 154 molecules, which play a pivotal role in cell-to-cell communication, on CD4
+ T cells and the percentage of B220
+ B cells increased only in Peyer's patches. Compared with systemic serum IgA, Peyer's patch-derived immunomodulation induced higher levels of intestinal IgA
+-producing cells in the lamina propria. Our data also showed that feeding with
Lactobacillus induced stronger CD4
+ T cell-dendritic cell interaction, enhanced CD4
+ T cell and B cell proliferation, and increased IL-1β, IL-10, IL-12, IFN-γ, and TNF-α mRNA expression in Peyer's patches, but not in the spleen. Here, we demonstrate that following
Lactobacillus treatment, Peyer's patches exhibited a more distinct capacity to induce CD4
+ T cell-dendritic cell interactions, lymphocyte proliferation, and cytokine secretion than the spleen, and thereby promoted greater intestinal IgA production that could enhance immunosurveillance to prevent intestinal infections or other intestinal pathologies. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 1567-5769 1878-1705 |
DOI: | 10.1016/j.intimp.2010.04.012 |